Product Information
LORAZEPAM 0.5 MG TABLET is a generic product labeled by Leading Pharma, LLC, priced at $0.0344 per EA under NDC 69315090405. Its NADAC has been published 538 times since Jun 15, 2016.
FDA first approved this application on Jul 30, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315090405
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA078203FDA Approved
7/30/2007
TE Code
AB
On Market Since
5/16/2023
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 0.5 MG TABLET has been published 538 times since Jun 15, 2016, and over the history we have for it it has risen 64.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0344 per EA |
|---|---|
| All-time high | $0.0464 (Mar 13, 2024) |
| All-time low | $0.0200 (Jun 22, 2016) |
| 52-week high | $0.0430 |
| 52-week low | $0.0328 |
| Median price | $0.0350 |
| Average price | $0.0337 |
| Largest weekly change | +30.1% (Dec 23, 2020) |
| Weeks tracked | 538 |
| Tracking since | Jun 15, 2016 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 41% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Leading Pharma, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lorazepam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LORAZEPAM 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 0.5 MG TABLET, manufactured by Leading Pharma, LLC, is $0.0344 per EA (NDC 69315090405), effective Sep 30, 2026.
How has the price of LORAZEPAM 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 0.5 MG TABLET has risen 64.7%. It has been tracked across 538 weekly CMS publications since Jun 15, 2016.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 0.5 MG TABLET?
Since Jun 15, 2016, the NADAC for LORAZEPAM 0.5 MG TABLET has ranged from a low of $0.0200 (Jun 22, 2016) to a high of $0.0464 (Mar 13, 2024), with a median of $0.0350 per EA.
Are there cheaper alternatives to LORAZEPAM 0.5 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LORAZEPAM 0.5 MG TABLET, is $0.0203 per EA — about 41% below LORAZEPAM 0.5 MG TABLET.
Who manufactures LORAZEPAM 0.5 MG TABLET?
LORAZEPAM 0.5 MG TABLET (NDC 69315090405) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.